BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9241659)

  • 1. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.
    Marez D; Legrand M; Sabbagh N; Lo Guidice JM; Spire C; Lafitte JJ; Meyer UA; Broly F
    Pharmacogenetics; 1997 Jun; 7(3):193-202. PubMed ID: 9241659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    Sachse C; Brockmöller J; Bauer S; Roots I
    Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.
    Daly AK; Fairbrother KS; Andreassen OA; London SJ; Idle JR; Steen VM
    Pharmacogenetics; 1996 Aug; 6(4):319-28. PubMed ID: 8873218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
    Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
    Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of CYP2D6 in the Japanese population.
    Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
    Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.
    Legrand-Andréoletti M; Stücker I; Marez D; Galais P; Cosme J; Sabbagh N; Spire C; Cenée S; Lafitte JJ; Beaune P; Broly F
    Pharmacogenetics; 1998 Feb; 8(1):7-14. PubMed ID: 9511176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
    Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
    Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
    Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
    Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population.
    Isaza CA; Henao J; López AM; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Nov; 22(9):695-705. PubMed ID: 11294012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan).
    Kouhi H; Hamzeiy H; Barar J; Asadi M; Omidi Y
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):665-70. PubMed ID: 19715474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
    Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
    Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction.
    Stüven T; Griese EU; Kroemer HK; Eichelbaum M; Zanger UM
    Pharmacogenetics; 1996 Oct; 6(5):417-21. PubMed ID: 8946473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2D6 genotyping in patients on psychoactive drug therapy.
    Topić E; Stefanović M; Ivanisević AM; Blazinić F; Culav J; Skocilić Z
    Clin Chem Lab Med; 2000 Sep; 38(9):921-7. PubMed ID: 11097351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population.
    Menoyo A; del Rio E; Baiget M
    Cell Biochem Funct; 2006; 24(5):381-5. PubMed ID: 16130179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequencies of mutated alleles of CYP2D6 gene in a Turkish population.
    Serin A; Canan H; Alper B; Gulmen M
    Forensic Sci Int; 2012 Oct; 222(1-3):332-4. PubMed ID: 22910059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients.
    López de Frutos L; Alfonso P; Lahoz C; Irún P; Giraldo P
    Med Clin (Barc); 2020 Dec; 155(12):529-534. PubMed ID: 32466973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.